Pharmacology News Digest, September 4th, 2018

 

This week in clinical pharmacology: ​​ 

 

The FDA approves​​ eravacycline​​ for abdominal infections and​​ doravirine​​ for HIV. ​​ Low-dose​​ rivaroxaban​​ does not lower cardiovascular risk in HF​​ without atrial fibrillation,​​ tafamidis​​ demonstrates efficacy in transthyretin amyloidosis, and​​ brexanolone​​ shows promise in post-partum depression.

 

-​​ September 4th, 2018

 


Continue reading “Pharmacology News Digest, September 4th, 2018”

Advertisements

Pharmacology News Digest, August 28th, 2018

 

 

This week in clinical pharmacology news: ​​ FDA approves new drugs for​​ neurotrophic keratitis, Dravet syndrome, and​​ hereditary angioedema. Glutamine shows promise in​​ post-infectious​​ IBS, any level of alcohol intake increases all-cause mortality, and aspirin is not effective in​​ primary prevention of cardiovascular disease.

-​​ August 27th, 2018

 


Continue reading “Pharmacology News Digest, August 28th, 2018”

Pharmacology Digest, July 29th, 2018

Continue reading “Pharmacology Digest, July 29th, 2018”

Pharmacology News Digest, July 22nd 2018

Continue reading “Pharmacology News Digest, July 22nd 2018”

Pharmacology News Digest, July 15th

Continue reading “Pharmacology News Digest, July 15th”